Government Drug Pricing Forum

Government Drug Pricing Forum
February 11-13, 2015
Embassy Suites Washington DC Convention Center, Washington. DC

With the increase in complexity of government pricing and contracting, the Conference Forum is no longer holding its Medicaid Rebate Summit. Instead, it is expanding its coverage and presenting the Government Drug Pricing Forum (GDP). The GDP Forum will cover changes in MDRP, 340B, Tricare and Medicaid Managed Care. It specifically addresses the AMP Final Rule, AMP-based FULs, proposed HRSA guidance, rise of contract pharmacies, and new state reporting requirements impact government and commercial contracting rules and operations. This event brings together CMS, FDA, IRS, HRSA, States and OIG to address how to be compliant with separate agency requirements.

Register today! Drug Channels readers receive a 15% discount with code DC15.

Featured Speakers include:

Lori Reilly, PhRMA	Laurel Todd, BIO
Don Bell, National Association Chain Drug Store (NACDS)	Ann Maxwell, Office of Evaluation and Inspections, Office of Inspector General
Andrew Wilson, McKesson	Alice Valder Curran, Hogan Lovells
John Shakow, King & Spaulding	Kathleen Black, Pfizer
George Kenny, Genentech	Stephanie Kupski, Iroko Pharmaceuticals
Ed McAdam, Daiichi Sankyo	Jay McKinley, Dendreon
Lorraine Moccio, Johnson & Johnson

Conference Topics

• Healthcare Trends and Policy Expectations: From ACOs and AMP to Contract Pharmacies

• New State Reporting Requirements and Tricare Contracting

• Drug Channel Contracting Strategies

• Compliant Government Pricing Programs

February 11th Workshop Choices

• Government Pricing Programs 101

• 340B Program Policies, Operational Answers, and Audits Findings 

Register today! Drug Channels readers receive a 15% discount with code DC15.